皇冠体育app

  Home>News Center>皇冠体育app
       
 

Roche licenses 皇冠体育app firm to produce Tamiflu
(AP/Xinhua)
Updated: 2005-12-12 19:57

Swiss drugmaker Roche Holding AG said Monday it has chosen 12 potential partners for the production of Tamiflu and granted one sublicense for the antiviral drug to Shanghai Pharmaceutical.


The Swiss pharmaceutical giant Roche said it had reached a sublicensing deal for production of its flagship anti-influenza drug Tamiflu in 皇冠体育app with Shanghai Pharmaceutical group. [AFP]

Roche said it will grant Shanghai Pharmaceutical rights for the overall production of Tamiflu, also known as oseltamivir, for use in 皇冠体育app.

"They are allowed to and they will produce the drug from the beginning to the end," said Piller.

Shanghai Pharmaceutical Group also announced the licensing agreement Monday at its website Monday, saying "Roche and Shanghai Pharmaceutical Group have signed the first sub-licensing agreement for the overall production of oseltamivir for pandemic use in 皇冠体育app."

An official with the Shanghai Pharmaceutical Group said its products will not bear the name of "Tamiflu", but the ingredients and quality will be the same with Tamiflu produced by Roche.

He said the group aims to form a monthly production capacity of 200,000 treatments in six months in the first step.

According to the official, the group made the request to produce and sell Tamiflu under a sub-license in November.

The announcement said Roche is also "in negotiations for local partnerships in other countries."

Roche said it compiled the shortlist of potential partners, which it did not identify, after evaluating around 200 applicants interested in helping with certain steps in the manufacture of Tamiflu. It didn't say how many it would finally choose.

Roche said it would mainly use the partners, which include major pharmaceutical makers, large generic manufacturers and specialty chemical producers, as backups, to meet specific regional needs and to prepare for any large additional government orders in the future.

"We are now also in the position to have a backup supply in case of an emergency," said David Reddy, who heads Roche's influenza pandemic task force.
Page: 12



Wen at ASEAN+3 summit
Chinese peacekeepers heading to Haiti
Harbin embraces snow sculpture festival
  Today's Top News     Top 皇冠体育app News
 

Wen: Growth poses no threat to neighbours

 

   
 

Roche licenses 皇冠体育app firm to produce Tamiflu

 

   
 

皇冠体育app's AIDS vaccine tests going 'smoothly'

 

   
 

皇冠体育app to probe "dodgy donation" from US

 

   
 

Early voting begins in Iraq; nine killed

 

   
 

Racial violence shocks Australian city

 

   
  Falling mercury fuels aid for the most needy
   
  Singh: India, 皇冠体育app not rivals
   
  50,000 corrupt officials punished in two years
   
  皇冠体育app denounces US criticism of human rights
   
  Qinghai-Tibet luxury trains to roll
   
  Lawyers arrive for chemical injury case
   
 
  Go to Another Section  
 
 
  Story Tools  
   
  Related Stories  
   
Roche in talks for Tamiflu production in 皇冠体育app
   
Bird flu kills Thai boy; reports paint bleak picture in US
   
Human case confirmed in Liaoning
   
皇冠体育app confirm fifth human case of bird flu
   
Study: Vaccine can stop poultry from spreading bird flu to each other
   
皇冠体育app: Bird flu virus in humans mutating
   
皇冠体育app human bird flu vaccine at least a year away
  News Talk  
   
Advertisement